Literature DB >> 20925597

Survivin: a target from brain cancer to neurodegenerative disease.

Sara Baratchi1, Rupinder K Kanwar, Jagat R Kanwar.   

Abstract

Apoptosis is an important contributing factor during neuronal death in a variety of neurodegenerative disorders, including multiple sclerosis, Parkinson's disease and sciatic nerve injury. Whereas several clinical and preclinical studies have focused on the neuroprotective effects of caspase inhibitors, their clinical benefits are still unclear. Here, we discuss novel alternative strategies to protect neuronal cells from apoptotic death using members of the inhibitors of apoptosis (IAP) family. We specifically review the different roles of survivin, which is an important member of the IAP family that serves a dual role in the inhibition of apoptosis as well as a vital role in mitosis and cell division. Due to the various roles of survivin during cell division and apoptosis, targeting this protein illustrates a new therapeutic window for the treatment of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20925597     DOI: 10.3109/10409238.2010.516740

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  16 in total

Review 1.  Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed?

Authors:  Sagar Kansara; Akash Trivedi; Sheng Chen; Joseph Jankovic; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2012-06-26       Impact factor: 3.575

2.  (-)-Epigallocatechin-3-gallate modulates spinal cord neuronal degeneration by enhancing growth-associated protein 43, B-cell lymphoma 2, and decreasing B-cell lymphoma 2-associated x protein expression after sciatic nerve crush injury.

Authors:  Waleed M Renno; May Al-Maghrebi; Muddanna S Rao; Haitham Khraishah
Journal:  J Neurotrauma       Date:  2014-11-10       Impact factor: 5.269

3.  Position of lipidation influences anticancer activity of Smac analogs.

Authors:  Ewa D Micewicz; Christine Nguyen; Alina Micewicz; Alan J Waring; William H McBride; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2019-04-26       Impact factor: 2.823

4.  Survivin Is a transcriptional target of STAT3 critical to estradiol neuroprotection in global ischemia.

Authors:  Yoshihide Sehara; Kirsty Sawicka; Jee-Yeon Hwang; Adrianna Latuszek-Barrantes; Anne M Etgen; R Suzanne Zukin
Journal:  J Neurosci       Date:  2013-07-24       Impact factor: 6.167

5.  Lipid-conjugated Smac analogues.

Authors:  Ewa D Micewicz; Josephine A Ratikan; Alan J Waring; Julian P Whitelegge; William H McBride; Piotr Ruchala
Journal:  Bioorg Med Chem Lett       Date:  2015-09-08       Impact factor: 2.823

6.  Upregulating the Expression of Survivin-HBXIP Complex Contributes to the Protective Role of IMM-H004 in Transient Global Cerebral Ischemia/Reperfusion.

Authors:  Shi-Feng Chu; Zhao Zhang; Wei Zhang; Mei-Jin Zhang; Yan Gao; Ning Han; Wei Zuo; Hui-Yong Huang; Nai-Hong Chen
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

7.  The dual behavior of PCSK9 in the regulation of apoptosis is crucial in Alzheimer's disease progression (Review).

Authors:  Qi Wu; Zhi-Han Tang; Juan Peng; Ling Liao; Li-Hong Pan; Chun-Yan Wu; Zhi-Sheng Jiang; Gui-Xue Wang; Lu-Shan Liu
Journal:  Biomed Rep       Date:  2013-12-30

8.  Protection effect of survivin protein overexpression on acute myocardial infarction in rats.

Authors:  Meng Yang; Bo Li; Jingwei Liu; Haiyan Sun
Journal:  Int J Clin Exp Med       Date:  2015-08-15

9.  Divergent modulation of neuronal differentiation by caspase-2 and -9.

Authors:  Giuseppa Pistritto; Veruska Papaleo; Pilar Sanchez; Claudia Ceci; Maria Luisa Barbaccia
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

10.  Survivin mutant protects differentiated dopaminergic SK-N-SH cells against oxidative stress.

Authors:  Sara Baratchi; Rupinder K Kanwar; Jagat R Kanwar
Journal:  PLoS One       Date:  2011-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.